Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 5.281
Filtrer
1.
Pain Physician ; 27(5): E637-E643, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-39087977

RÉSUMÉ

BACKGROUND: A pain drawing is a self-administered assessment that requires the patient to shade in on a body chart the areas in which he or she experiences pain, regardless of the intensity. Pain drawings have already been validated in several adult populations. OBJECTIVES: The aim of this study is to establish adolescents' test-retest reliability in reporting the extent and location of their pain using a paper-based pain drawing. STUDY DESIGN: A one-day test-retest reliability study was set up. SETTING: The study took place in 2 separate locations-a pediatric hospital and a private physiotherapy practice in Ticino, in the southern part of Switzerland. This reliability study was approved by the local ethics committee of Ticino (2021-00492 CE 3832). METHODS: Adolescents with musculoskeletal pain (aged 11-16 years) were included. All participants were asked to shade the areas in which they experienced pain over the previous week. After the administration of a questionnaire and the acquisition of further personal data, the pain drawing was administered again. The pain drawings were then scanned and analyzed using a digital platform, which allowed the extraction of pain extent and location values. The test-retest reliability was evaluated on these data. The intraclass correlation coefficient and Bland-Altman analysis were used to assess the reliability of the reporting of the pain extent, whereas the Jaccard similarity coefficient was used to calculate the reliability of the reporting of the pain location. RESULTS: The reporting of the pain extent was observed to have excellent test-retest reliability: ICC2,1: 0.959 (95% CI: 0.925-0.978). The Bland-Altman analysis showed a mean difference close to 0: -0.010% (limits of agreements -0.962 to 0.942). The reliability of the reporting of pain location was also supported by the Jaccard index mean score of 0.82 (± 0.19). LIMITATIONS: Reliability of reporting may vary depending on the nature of the pain, its duration, or the type of disorder and body areas involved. CONCLUSIONS: Adolescents complaining musculoskeletal pain showed reliability in reporting pain extent and location using pain drawings.


Sujet(s)
Douleur musculosquelettique , Mesure de la douleur , Humains , Adolescent , Reproductibilité des résultats , Mesure de la douleur/méthodes , Femelle , Enfant , Mâle , Douleur musculosquelettique/diagnostic , Enquêtes et questionnaires
2.
BMC Musculoskelet Disord ; 25(1): 574, 2024 Jul 23.
Article de Anglais | MEDLINE | ID: mdl-39044247

RÉSUMÉ

BACKGROUND: Excessive smartphone usage among students can lead to discomfort in their hands and fingers. This study investigates the impact of smartphone holding posture, duration of usage, and the prevalence of wrist and finger pain among university students. METHODS: This cross-sectional study involved 213 university students who were selected based on inclusion criteria. Data was collected through a demographic information questionnaire. Participants self-reported five different postures for holding and interacting with a smartphone. The prevalence, frequency, severity, and interference of wrist and finger discomfort were assessed using the Cornell Hand Discomfort Questionnaires (CHDQ). RESULTS: The study revealed that the average age of participants was 21.3 ± 2.2 years. On average, they had been using smartphones for 7.9 ± 3.1 years and spent an average of 4.9 ± 2.5 h daily holding them in their hands. In terms of discomfort, more than 25% of students reported pain in areas C (thumb finger), E (Palm Pollicis), and F (wrist) of the right hand, which was significantly related to the duration of holding the smartphone in that hand. Additionally, smartphone holding duration significantly affected areas D (palm) and F of the left hand, with over 11% of students experiencing discomfort. The most prevalent posture among students (41% of participants) involved holding the smartphone with the right hand only, with the thumb touching the screen. Notably, areas B (χ2 = 21.7), C (χ2 = 10.27), D (χ2 = 65.54), and E (χ2 = 59.49) of the right hand, as well as areas C (χ2 = 6.58) and E (χ2 = 44.28) of the left hand, exhibited significant associations with the postures of holding the smartphone. CONCLUSIONS: The duration of smartphone use and the postures in which it is held contribute to the prevalence of discomfort in the thumb area and related muscles among right-handed students.


Sujet(s)
Posture , Ordiphone , Étudiants , Humains , Femelle , Mâle , Études transversales , Jeune adulte , Prévalence , Étudiants/statistiques et données numériques , Universités , Main/physiopathologie , Facteurs temps , Enquêtes et questionnaires , Douleur musculosquelettique/épidémiologie , Douleur musculosquelettique/diagnostic , Douleur musculosquelettique/étiologie , Adulte
3.
Orthopedics ; 47(4): e214-e216, 2024.
Article de Anglais | MEDLINE | ID: mdl-39038107

RÉSUMÉ

Orthopedic surgery is a physically demanding specialty. The factors contributing to musculoskeletal injury among surgeons often stem from positioning the patient, using non-ergonomic instruments, maintaining static postures, and performing repetitive movements. This article focuses on exercise techniques intended to combat the most common problematic static postures held during procedures. Each exercise explained in this article is organized into "preop," "intraop," and "postop" components. Preop includes strengthening movements, intraop provides postural recommendations, and postop focuses on mobilization and recovery. This article aims for efficient body conditioning, targeting the muscular posterior chain and supporting elements. [Orthopedics. 2024;47(4):e214-e216.].


Sujet(s)
Douleur musculosquelettique , Chirurgiens orthopédistes , Humains , Douleur musculosquelettique/prévention et contrôle , Douleur musculosquelettique/étiologie , Traitement par les exercices physiques/méthodes , Maladies professionnelles/prévention et contrôle , Maladies professionnelles/étiologie , Posture
4.
Hum Brain Mapp ; 45(10): e26780, 2024 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-38984446

RÉSUMÉ

Past cross-sectional chronic pain studies have revealed aberrant resting-state brain activity in regions involved in pain processing and affect regulation. However, there is a paucity of longitudinal research examining links of resting-state activity and pain resilience with changes in chronic pain outcomes over time. In this prospective study, we assessed the status of baseline (T1) resting-state brain activity as a biomarker of later impairment from chronic pain and a mediator of the relation between pain resilience and impairment at follow-up. One hundred forty-two adults with chronic musculoskeletal pain completed a T1 assessment comprising a resting-state functional magnetic resonance imaging scan based on regional homogeneity (ReHo) and self-report measures of demographics, pain characteristics, psychological status, pain resilience, pain severity, and pain impairment. Subsequently, pain impairment was reassessed at a 6-month follow-up (T2). Hierarchical multiple regression and mediation analyses assessed relations of T1 ReHo and pain resilience scores with changes in pain impairment. Higher T1 ReHo values in the right caudate nucleus were associated with increased pain impairment at T2, after controlling for all other statistically significant self-report measures. ReHo also partially mediated associations of T1 pain resilience dimensions with T2 pain impairment. T1 right caudate nucleus ReHo emerged as a possible biomarker of later impairment from chronic musculoskeletal pain and a neural mechanism that may help to explain why pain resilience is related to lower levels of later chronic pain impairment. Findings provide empirical foundations for prospective extensions that assess the status of ReHo activity and self-reported pain resilience as markers for later impairment from chronic pain and targets for interventions to reduce impairment. PRACTITIONER POINTS: Resting-state markers of impairment: Higher baseline (T1) regional homogeneity (ReHo) values, localized in the right caudate nucleus, were associated with exacerbations in impairment from chronic musculoskeletal pain at a 6-month follow-up, independent of T1 demographics, pain experiences, and psychological factors. Mediating role of ReHo values: ReHo values in the right caudate nucleus also mediated the relationship between baseline pain resilience levels and later pain impairment among participants. Therapeutic implications: Findings provide empirical foundations for research extensions that evaluate (1) the use of resting-state activity in assessment to identify people at risk for later impairment from pain and (2) changes in resting-state activity as biomarkers for the efficacy of treatments designed to improve resilience and reduce impairment among those in need.


Sujet(s)
Douleur chronique , Imagerie par résonance magnétique , Repos , Humains , Mâle , Femelle , Douleur chronique/physiopathologie , Douleur chronique/imagerie diagnostique , Adulte , Adulte d'âge moyen , Encéphale/imagerie diagnostique , Encéphale/physiopathologie , Douleur musculosquelettique/physiopathologie , Douleur musculosquelettique/imagerie diagnostique , Résilience psychologique , Études prospectives , Marqueurs biologiques , Études longitudinales , Études de suivi
5.
PLoS One ; 19(7): e0305931, 2024.
Article de Anglais | MEDLINE | ID: mdl-39024361

RÉSUMÉ

BACKGROUND: Disordered sleep and persistent musculoskeletal pain are highly comorbid. Behavioural interventions such as Cognitive Behavioural Therapy for Insomnia (CBT-I) have shown promise in the management of both disordered sleep and persistent musculoskeletal pain. The aim of this review was to examine how CBT-I is delivered in randomised controlled trials involving people with comorbid disordered sleep and persistent musculoskeletal pain. METHODS: The protocol for this scoping review was registered with the Open Science Framework. Electronic searches of ten database and three clinical trials registries were performed up to 25 October 2023. The methodological quality of each study was evaluated by two independent reviewers using the PEDro tool. The reporting of CBT-I interventions was evaluated using the Template for Intervention Description and Replication (TIDieR) checklist. RESULTS: Twelve studies met the eligibility criteria. TIDieR scores ranged from 7-11/12, with a mean score of 8.8/12. CBT-I always involved two core components-sleep restriction and stimulus control. Furthermore, an additional five components were usually involved-a cognitive component, sleep hygiene, sleep education, relaxation/deactivation procedures and relapse planning. There was also considerable consistency in the frequency (weekly) and duration (5-9 weeks) of CBT-I programmes. Aspects inconsistently reported included who delivered the intervention; what modifications were made, if any; and the session content and duration. PEDro scores ranged from 5-8/10, with a mean score of 6.7/10. CONCLUSIONS: These findings demonstrate considerable consistency in the components of CBT-I delivered in clinical trials along with the number of sessions. The frequency of sessions was also consistent where almost all studies held weekly session. However, some aspects were either not reported (e.g., precise content of components) or inconsistent (e.g., use of terminology). CBT-I was delivered both individually and in groups. Greater consistency, and more detailed reporting regarding who delivered the intervention, the training provided, and the specific content of CBT-I components would add clarity, and may enhance CBT-I efficacy and allow better replication.


Sujet(s)
Thérapie cognitive , Douleur musculosquelettique , Troubles de l'endormissement et du maintien du sommeil , Humains , Thérapie cognitive/méthodes , Troubles de l'endormissement et du maintien du sommeil/thérapie , Douleur musculosquelettique/thérapie , Adulte , Troubles de la veille et du sommeil/thérapie , Comorbidité , Essais contrôlés randomisés comme sujet
6.
Article de Anglais | MEDLINE | ID: mdl-39063422

RÉSUMÉ

Chronic musculoskeletal pain (CMP) is a global health condition that affects thousands of people. CMP can substantially affect the functional capacity and quality of life of the people impacted, resulting in high costs for health care and social security systems. Sociodemographic factors may play a significant role in pain chronification prevention and control programs. Thus, current risk factors for CMP must be seriously considered as part of an interdisciplinary management strategy. The purpose of the study was to identify the primary sociodemographic characteristics of CMP patients at a multidisciplinary and specialized center for chronic pain. This is a retrospective investigation based on a review of medical records. Age, gender, income, and the time of onset of pain symptoms were among the variables included in the analyzed data. To analyze variables related to the duration of discomfort, a multiple regression model was utilized. Sociodemographic factors explained 37.94% of experiencing prolonged pain, according to the study's findings. Being female and having a family income above the minimum wage were variables that were directly proportional to discomfort duration. Age was not associated with a prolonged duration of pain perception.


Sujet(s)
Douleur chronique , Humains , Femelle , Mâle , Adulte d'âge moyen , Études rétrospectives , Adulte , Douleur chronique/thérapie , Sujet âgé , Douleur musculosquelettique/épidémiologie , Douleur musculosquelettique/thérapie , Facteurs socioéconomiques , Jeune adulte , Gestion de la douleur , Facteurs sociodémographiques , Facteurs de risque
7.
Medicine (Baltimore) ; 103(27): e38698, 2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-38968530

RÉSUMÉ

Sleep inadequacy has previously been associated with increased risk of injury and reduced performance. It is unclear if sleep disorders are associated with musculoskeletal symptoms, which may be a predictor of serious injury and affect performance. The aim was therefore to assess sleep behavior in elite junior badminton players and its association to musculoskeletal symptoms. In 2018, players at the World Junior Badminton Championship completed the Athlete Sleep Behavior Questionnaire and a modified version of the World Olympic Association Musculoskeletal Health Questionnaire. Participants were categorized with poor or moderate/good sleep behavior as the independent variable. Musculoskeletal symptoms were the primary outcome and was categorized using yes/no questions. Relevant musculoskeletal symptoms were defined as pain higher than 30 mm Numeric Rating Scale pain score or more than 30 minutes of joint stiffness a day. Group comparison was performed using chi-square analysis and logistic regression for primary outcome adjusted for age, sex, ethnicity, previous injury, training load, and resting days. Of the 153 participants, 28% reported poor sleep scores. There was no difference between poor and moderate/good sleep score concerning demographic variables such as sex, age, ethnicity, previous injury, training load, and resting days. There were 27% with current musculoskeletal symptoms but with no difference in groups between poor and moderate/good sleep score (P = .376). This yielded an adjusted odds ratio of 1.23 (95% confidence intervals 0.52; 2.90). Twenty-eight percent of the participants reported poor sleep behavior. Twenty-seven percent experienced current musculoskeletal symptoms. We found no statistical differences in reported musculoskeletal symptoms when comparing athletes with poor sleep behavior to athletes with moderate/good sleep behavior.


Sujet(s)
Sports de raquette , Humains , Mâle , Études transversales , Sports de raquette/traumatismes , Femelle , Adolescent , Enquêtes et questionnaires , Athlètes/statistiques et données numériques , Troubles de la veille et du sommeil/épidémiologie , Maladies ostéomusculaires/épidémiologie , Maladies ostéomusculaires/physiopathologie , Sommeil/physiologie , Douleur musculosquelettique/épidémiologie
8.
J Coll Physicians Surg Pak ; 34(7): 817-821, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38978247

RÉSUMÉ

OBJECTIVE: To determine the frequency and pattern of different aetiologies of leg pain among patients visiting vascular surgery clinics. STUDY DESIGN: Cross-sectional study. Place and Duration of the Study: Vascular Surgery Clinics of the Aga Khan University Hospital, Karachi, Pakistan, between February 2021 and June 2023. METHODOLOGY: This study examined patients presenting with leg pain for the first time at vascular surgery clinics. The socio-demographic and clinical data including the clinical symptoms, physical examination findings, and management of leg pain were noted using a specially designed proforma. RESULTS: In a total of 142 patients (200 limbs), 82 (57.7%) were females and 60 (42.3%) were males, with a mean age of 46.8 ± 15.1 years. The patients' mean body mass index (BMI) was 30.2 ± 7.9 kg/m2. Ninety-one (64.1%) patients had a predominantly standing job compared to 51 (35.9%) patients who had a predominantly sitting job. The most common aetiology of leg pain was chronic venous insufficiency (CVI), diagnosed in 107 (53.5%) patients, followed by neurogenic pain [41 (20.5%)], musculoskeletal pain including knee osteoarthritis [30 (15.0%)], and arterial insufficiency [22 (11.0%)].  Conclusion: CVI followed by neuropathic pain was the leading cause of leg pain in vascular surgery clinics at a tertiary care hospital. KEY WORDS: Chronic venous insufficiency, Arterial insufficiency, Vascular surgery, Leg pain, Musculoskeletal pain, Neuralgia.


Sujet(s)
Jambe , Humains , Femelle , Mâle , Adulte d'âge moyen , Études transversales , Pakistan/épidémiologie , Adulte , Jambe/vascularisation , Procédures de chirurgie vasculaire , Douleur/étiologie , Douleur/épidémiologie , Névralgie/étiologie , Névralgie/épidémiologie , Sujet âgé , Douleur musculosquelettique/épidémiologie , Douleur musculosquelettique/étiologie
9.
J Pak Med Assoc ; 74(6): 1199-1201, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38949004

RÉSUMÉ

Musculoskeletal (MSK) disorders encompass various conditions impacting bones, muscles, tendons, ligaments, and nerves. An estimated 1.71 billion individuals globally have MSK disorders, causing disability and reduced quality of life. Literature contradicts the notion that musculoskeletal pain and disability solely arise from physical impairments; psychological, behavioural, and social factors contribute significantly. These facets influence pain perception and chronic impairment development. Common interventions-medication, exercise, manual and hydrotherapy, electro-thermal modalities, behavioural and alternative therapies-address pain individually, yet lack the comprehensive response required. In contrast, a multimodal approach combines diverse therapies tailored to individual needs. It ensures lasting symptom relief, prevents recurrence, and improves function. Although proven effective, clinical implementation of this approach remains limited. This mini-review discusses the reasons behind this gap, underscores multimodal approach importance, and enlightens rehabilitation professionals on its potential for managing chronic musculoskeletal issues.


Sujet(s)
Maladies ostéomusculaires , Humains , Maladies ostéomusculaires/thérapie , Association thérapeutique , Douleur musculosquelettique/thérapie , Maladie chronique , Traitement par les exercices physiques/méthodes
10.
Article de Anglais | MEDLINE | ID: mdl-38975684

RÉSUMÉ

BACKGROUND: It is unknown whether growth differentiation factor 15 (GDF-15) is associated with chronic musculoskeletal pain (CMP) and whether or not its association with incident cardiovascular disease (CVD) changes according to CMP status. METHODS: In total, 1 957 randomly selected adults aged ≥65 years without prior CVD were followed up between 2015 and 2023. CMP was classified according to its intensity, frequency, and interference with daily activities. The association between GDF-15 levels and CMP was assessed using linear models with progressive inclusion of potential confounders, whereas the association between GDF-15 and CVD risk was evaluated with Cox proportional hazard models with similar adjustment and interaction terms between GDF-15 and CMP. The incremental predictive performance of GDF-15 over standard predictors was evaluated using discrimination and risk reclassification metrics. RESULTS: GDF-15 concentrations were 6.90% (95% confidence interval [CI]: 2.56; 11.25) higher in individuals with CMP, and up to 8.89% (4.07; 15.71) and 15.79% (8.43; 23.16) higher in those with ≥3 CMP locations and interfering pain. These increased levels were influenced by a higher prevalence of cardiometabolic risk factors, functional impairments, depressive symptoms, and greater levels of inflammation in individuals with CMP. In fully adjusted models, a twofold increase in GDF-15 was associated with a 1.49 increased risk (95% CI: 1.08; 2.05) of a CVD event in individuals with CMP, but not among those without CMP (1.02 [0.77; 1.35]); p-interaction 0.041. Adding GDF-15 to models including the Framingham Risk Score improved predictive performance among individuals with CMP. CONCLUSIONS: We provide evidence that GDF-15 could serve as a biomarker to assess CMP, as well as to predict CVD incidence in individuals with CMP.


Sujet(s)
Marqueurs biologiques , Maladies cardiovasculaires , Douleur chronique , Facteur-15 de croissance et de différenciation , Douleur musculosquelettique , Humains , Facteur-15 de croissance et de différenciation/sang , Mâle , Femelle , Douleur musculosquelettique/épidémiologie , Douleur musculosquelettique/sang , Marqueurs biologiques/sang , Sujet âgé , Maladies cardiovasculaires/épidémiologie , Maladies cardiovasculaires/sang , Douleur chronique/épidémiologie , Douleur chronique/sang , Facteurs de risque de maladie cardiaque , Appréciation des risques/méthodes , Facteurs de risque
11.
J Med Life ; 17(4): 397-405, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-39071517

RÉSUMÉ

Premenstrual syndrome (PMS) has various symptoms that occur during the luteal phase of the menstrual cycle and subside after menstruation. Anxiety and depression are prevalent in women with PMS and may exacerbate the severity of PMS. Vitamin D and calcium deficiency may have a role in developing anxiety, depression, and musculoskeletal pain (MSP). The aim of this study was to evaluate selected premenstrual symptoms in relation to serum vitamin D levels, daily calcium consumption, and psychological symptoms among women with MSP. The study population consisted of 108 women with MSP and 108 healthy controls. Information about premenstrual symptoms and calcium consumption were collected. Psychological symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS). Vitamin D was determined by electrochemiluminescence immunoassay. Women with MSP had lower serum vitamin D levels, lower daily calcium consumption, higher HADS scores for anxiety and depression, and higher frequency of severe premenstrual symptoms including fatigue, headache, irritability, mood swings, anxiety, depression, and social withdrawal compared to controls (P < 0.01). Abnormal HADS scores for anxiety and depression were associated with increased severity of premenstrual symptoms (P < 0.05). Deficient vitamin D and calcium consumption were associated with abnormal HADS scores for anxiety and depression (P < 0.05) and with increased severity of premenstrual headache, irritability, anxiety, and depression (P < 0.05). Low calcium consumption was associated with increased severity of premenstrual irritability, anxiety, depression, and social withdrawal (P < 0.05). The results suggest that vitamin D deficiency, low calcium consumption, psychological symptoms, and MSP could be interrelated and implicated in the etiology severe premenstrual symptoms. Further studies are necessary to assess whether vitamin D and calcium supplements can relieve MSP and premenstrual symptoms.


Sujet(s)
Calcium , Dépression , Douleur musculosquelettique , Syndrome prémenstruel , Vitamine D , Humains , Femelle , Syndrome prémenstruel/sang , Syndrome prémenstruel/psychologie , Vitamine D/sang , Adulte , Douleur musculosquelettique/sang , Douleur musculosquelettique/psychologie , Calcium/sang , Dépression/sang , Anxiété/sang , Indice de gravité de la maladie , Carence en vitamine D/complications , Carence en vitamine D/sang , Carence en vitamine D/psychologie , Études cas-témoins , Jeune adulte
12.
BMJ Open ; 14(7): e082611, 2024 Jul 30.
Article de Anglais | MEDLINE | ID: mdl-39079926

RÉSUMÉ

INTRODUCTION: Many individuals receiving outpatient physical therapy have musculoskeletal pain and up to one-third use prescription opioids. The impact of physical therapist-led mindfulness-based interventions integrated with evidence-based physical therapy (I-EPT) to manage patients with chronic musculoskeletal pain and long-term opioid treatment has not been elucidated. This project evaluates the feasibility of conducting a cluster randomised trial to test the effectiveness of I-EPT. METHODS AND ANALYSIS: Study 1 aim: Refine and manualise the I-EPT treatment protocol. Our approach will use semistructured interviews of patients and physical therapists to refine an I-EPT training manual. Study 2 aim: Evaluate different intensities of physical therapist training programmes for the refined I-EPT treatment protocol. Physical therapists will be randomised 1:1:1 to high-intensity training (HighIT), low-IT (LowIT) training and no training arms. Following training, competency in the provision of I-EPT (LowIT and HighIT groups) will be assessed using standardised patient simulations. Study 3 aim: Evaluate the feasibility of the I-EPT intervention across domains of the Reach, Effectiveness, Adoption, Implementation, Maintenance implementation framework. The refined I-EPT treatment protocol will be tested in two different health systems with 90 patients managed by the randomised physical therapists. The coprimary endpoints for study 3 are the proportions of the Pain, Enjoyment of Life and General Activity Scale and the Timeline Followback for opioid use/dose collected at 12 weeks. ETHICS AND DISSEMINATION: Ethics approval for the study was obtained from the University of Utah, University of Florida and Florida State University Institutional Review Boards. Informed consent is required for participant enrolment in all phases of this project. On completion, study data will be made available in compliance with NIH data sharing policies. TRIAL REGISTRATION NUMBER: NCT05875207.


Sujet(s)
Analgésiques morphiniques , Douleur chronique , Études de faisabilité , Pleine conscience , Douleur musculosquelettique , Techniques de physiothérapie , Humains , Pleine conscience/méthodes , Douleur musculosquelettique/thérapie , Douleur chronique/thérapie , Analgésiques morphiniques/usage thérapeutique , Analgésiques morphiniques/administration et posologie , Essais contrôlés randomisés comme sujet , Études multicentriques comme sujet
13.
Rev Med Suisse ; 20(879): 1209-1213, 2024 Jun 19.
Article de Français | MEDLINE | ID: mdl-38898757

RÉSUMÉ

The majority of patients following musculoskeletal rehabilitation are taking painkillers. However, apart from one recent observational study, there is a lack of data. The use of analgesics, particularly opioids, is associated with higher scores for pain, anxiety, depression, catastrophizing and disability, as well as poorer results in functional tests. Prescribing analgesic treatment with precise objectives (improving pain and function) should also include identifying psychosocial factors associated with a poor prognosis. Regular reassessment of the treatment should make it possible to limit side-effects and the risk of misuse and help patients to engage in an active rehabilitation programme and resume regular physical activity.


La majorité des patients effectuant une réadaptation musculosquelettique consomme des antalgiques. Cependant, en dehors d'une étude observationnelle récente, les données manquent. La prise d'antalgiques, en particulier les opioïdes, est associée à des scores de douleur, d'anxiété, de dépression, de catastrophisme et de handicap élevés, ainsi qu'à des résultats plus faibles aux tests fonctionnels. La prescription d'un traitement antalgique avec des objectifs précis (amélioration de la douleur et de la fonction) doit également comporter une détection des facteurs psychosociaux de mauvais pronostic. Une réévaluation régulière de la prescription devrait permettre de limiter les effets secondaires, les risques de mésusage et aider les patients à s'engager dans un programme de réadaptation actif et à reprendre une activité physique régulière.


Sujet(s)
Douleur chronique , Humains , Douleur chronique/rééducation et réadaptation , Douleur chronique/psychologie , Analgésiques/usage thérapeutique , Analgésiques/administration et posologie , Maladies ostéomusculaires/rééducation et réadaptation , Analgésiques morphiniques/administration et posologie , Analgésiques morphiniques/effets indésirables , Analgésiques morphiniques/usage thérapeutique , Douleur musculosquelettique/rééducation et réadaptation , Douleur musculosquelettique/thérapie
14.
J Health Care Poor Underserved ; 35(2): 564-582, 2024.
Article de Anglais | MEDLINE | ID: mdl-38828582

RÉSUMÉ

Background Black individuals with chronic musculoskeletal (MSK) pain tend to experience worse pain and opioid use-related outcomes, including other substance co-use, compared with non-Hispanic White individuals. Co-using cannabis with opioids could instigate a cascade of pain-related vulnerabilities and poor outcomes. Here, we test associations between cannabis/opioid co-use and pain-related outcomes among Black individuals with chronic MSK pain. Methods Black adults with chronic MSK pain who use opioids (N=401; 51.62% female, Mage=35.90, SD=11.03) completed online measures of pain intensity/interference, emotional distress, opioid dependence, and risky use of other substances. Results Compared with opioid use alone, opioid and cannabis co-use was associated with elevated anxiety and depression symptoms, opioid dependence, and risky substance use, but not pain. Conclusions Black individuals with chronic MSK pain who co-use opioids and cannabis warrant targeted interventions that address their needs. Tailored interventions could help address disparities in pain-related outcomes and opioid morbidity and mortality rates.


Sujet(s)
Analgésiques morphiniques , , Douleur chronique , Troubles liés aux opiacés , Humains , Femelle , Douleur chronique/traitement médicamenteux , Douleur chronique/ethnologie , Adulte , Mâle , Analgésiques morphiniques/administration et posologie , Analgésiques morphiniques/effets indésirables , /statistiques et données numériques , /psychologie , Troubles liés aux opiacés/ethnologie , Troubles liés aux opiacés/épidémiologie , Adulte d'âge moyen , Douleur musculosquelettique/ethnologie , Douleur musculosquelettique/épidémiologie , Troubles liés à une substance/épidémiologie , Troubles liés à une substance/ethnologie , Dépression/épidémiologie , Dépression/ethnologie
15.
Scand J Pain ; 24(1)2024 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-38907605

RÉSUMÉ

OBJECTIVES: Pain is still a neglected problem in mild traumatic brain injury (mTBI). In this cross-sectional study, we examined the frequency of musculoskeletal pain in a sample of adult patients with persistent cognitive symptoms after mTBI and whether pain level affected cognition. METHODS: The participants were 23 adult patients aged 18-50 referred to brain injury rehabilitation clinics for neuropsychological assessment after having sustained an mTBI. A non-injured control group (n = 29) was recruited through advertisements. The patients were, on average, assessed 22 months after trauma. All participants completed a comprehensive neuropsychological test battery and completed the Örebro Musculoskeletal Pain Screening Questionnaire, The Rivermead Post-Concussion Symptoms Questionnaire, and the State-Trait Anxiety Inventory. RESULTS: Patients reported high levels of current pain and significantly more frequent neck and shoulder pain than the non-injured controls. Patients also reported high post-concussive symptoms and anxiety levels and performed less well on several neuropsychological tests. Pain level was associated with slower processing speed among the controls but not related to performance in the mTBI group. CONCLUSION: We conclude that musculoskeletal pain is frequent in mTBI patients referred to rehabilitation settings. Furthermore, the results indicate that the interaction between pain and cognitive functioning differs in mTBI compared to controls. Our results implicate that pain screening should be an integrated part of neuropsychological rehabilitation after mTBI to identify conditions that run the risk of becoming chronic. The study was approved by the Regional Ethical Board in Stockholm, Sweden (04-415/2).


Sujet(s)
Commotion de l'encéphale , Tests neuropsychologiques , Humains , Mâle , Femelle , Adulte , Études transversales , Commotion de l'encéphale/complications , Commotion de l'encéphale/psychologie , Adulte d'âge moyen , Jeune adulte , Douleur musculosquelettique/psychologie , Cognition , Anxiété/étiologie , Anxiété/épidémiologie , Adolescent , Syndrome post-commotionnel/psychologie
16.
Harefuah ; 163(6): 376-381, 2024 Jun.
Article de Hébreu | MEDLINE | ID: mdl-38884292

RÉSUMÉ

INTRODUCTION: Fibromyalgia syndrome (FMS) is a chronic pain syndrome, prevalent in women more than men. The main symptoms are widespread musculoskeletal pain, fatigue, and weakness. To date, the pathophysiological mechanisms are unclear, and there are several pathogenic theories elucidating this condition. In this review, we summarized articles published in the past few years, regarding the effect of musculoskeletal dysfunction on FMS. We focused on the musculoskeletal system and central nervous system (CNS) disarrays.


Sujet(s)
Fibromyalgie , Fibromyalgie/physiopathologie , Humains , Femelle , Mâle , Fatigue/physiopathologie , Fatigue/étiologie , Douleur chronique/physiopathologie , Douleur chronique/étiologie , Système nerveux central/physiopathologie , Douleur musculosquelettique/physiopathologie , Douleur musculosquelettique/étiologie , Faiblesse musculaire/physiopathologie , Faiblesse musculaire/étiologie
17.
Rev Lat Am Enfermagem ; 32: e4176, 2024.
Article de Anglais, Espagnol, Portugais | MEDLINE | ID: mdl-38922262

RÉSUMÉ

OBJECTIVE: to analyze exposure to ergonomic risks and the occurrence of musculoskeletal pain in workers in the Hospital Cleaning Service. METHOD: Convergent Care Research, with data production designed using mixed methods, implemented with 149 hospital cleaning workers. The methodological strategy of the convergent parallel project was employed, using observation, photographic records, questionnaires and convergence groups. The results were integrated through joint display. Data analysis with descriptive and inferential statistics and content analysis. RESULTS: the mixing of data highlighted the multifactorial nature of exposure to ergonomic risks (uncomfortable work postures; repetitive movements; prolonged orthostatism; use of equipment not adapted to the psychophysiological needs of workers) and musculoskeletal pain in the population investigated. The latter was prevalent in the lumbar spine, ankles or feet, wrists or hands, thoracic spine and shoulders. The concept of ergonomic risk was expanded and was influenced by the psychosocial aspects of work. CONCLUSION: the workers investigated are exposed to modifiable multifactorial ergonomic risks related to musculoskeletal pain. It is possible to promote innovations and teaching-learning actions to minimize them, such as the continuing education program, collectively constructed with recommendations for improvements.


Sujet(s)
Ingénierie humaine , Service hospitalier d'entretien ménager , Douleur musculosquelettique , Maladies professionnelles , Humains , Maladies professionnelles/épidémiologie , Maladies professionnelles/étiologie , Douleur musculosquelettique/épidémiologie , Douleur musculosquelettique/étiologie , Mâle , Femelle , Adulte , Adulte d'âge moyen , Facteurs de risque
18.
J Bodyw Mov Ther ; 39: 50-56, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38876675

RÉSUMÉ

BACKGROUND: Chronic pain affects 11% of the US population. Most patients who experience pain, particularly chronic musculoskeletal pain, seek care in primary care settings. Assessment of the patient pain experience is the cornerstone to optimal pain management; however, pain assessment remains a challenge for medical professionals. It is unknown to what extent the assessment of pain intensity is considered in context of function and quality of life. OBJECTIVE: To understand common practices related to assessment of pain and function in patients with chronic musculoskeletal disorders. DESIGN: Cross-sectional survey. METHODS: A 42-item electronic survey was developed with self-reported numeric ratings and responses related to knowledge, beliefs, and current practices. All physicians and non-physician clinicians affiliated with the AAFP NRN and 2000 AAFP physician members were invited to participate. RESULTS/FINDINGS: Primary care clinicians report that chronic joint pain assessment should be comprehensive, citing assessment elements that align with the comprehensive pain assessment models. Pain intensity remains the primary focus of pain assessment in chronic joint pain and the most important factor in guiding treatment decisions, despite well-known limitations. Clinicians also report that patients with osteoarthritis should be treated by Family Medicine. CONCLUSIONS: Pain assessment is primarily limited to pain intensity scales which may contribute to worse patient outcomes. Given that most respondents believe primary care/family medicine should be primary responsible for the care of patients with osteoarthritis, awareness of and comfort with existing guidelines, validated assessment instruments and the comprehensive pain assessment models could contribute to delivery of more comprehensive care.


Sujet(s)
Douleur chronique , Douleur musculosquelettique , Mesure de la douleur , Humains , Douleur musculosquelettique/thérapie , Études transversales , Douleur chronique/thérapie , Mesure de la douleur/méthodes , Médecine de famille/méthodes , Femelle , Gestion de la douleur/méthodes , Mâle , Types de pratiques des médecins/statistiques et données numériques , Soins de santé primaires , Qualité de vie , Adulte d'âge moyen , Adulte
19.
Trials ; 25(1): 406, 2024 Jun 21.
Article de Anglais | MEDLINE | ID: mdl-38907349

RÉSUMÉ

BACKGROUND: Due to the burden of musculoskeletal diseases in the elderly and the multifactorial nature of such conditions, controlling the pain caused by these disorders requires multidisciplinary approach. This approach requires the participation of the elderly in applying effective prevention measures. This study aims to design a multidisciplinary educational intervention based on health belief model (HBM) for elderly residents of nursing homes. METHODS: This is a parallel randomized clinical trial among elderly people aged 60 years and over living in a nursing home who suffer from musculoskeletal pain. Eligible participants will be divided into two groups including the intervention group who will receive a multidisciplinary intervention (vitamin D consumption, psycho-social stress management, and physiotherapy) and the control group who will receive usual care. Data collection instruments will include demographic data, the Depression, Anxiety, and Stress Scale (DASS), the visual analogue scale (VAS), and a self-designed questionnaire containing the HBM constructs. The interventions will be carried out by the educational team (general practitioner, psychologist, physiotherapist, and health education specialist). Interventions include changing the wrong beliefs of the elderly, taking 800 units of vitamin D daily, daily walking exercise by the elderly for at least 30 min and maintaining proper body posture during daily activities, muscle relaxation, relaxation techniques, regular exercise, examining their diet and eliminating stimulants (such as smoking and coffee), regular visits with friends and family, and deep breathing techniques. All questionnaires will be completed by the elderly before, after, 3, and 6 months after the intervention. DISCUSSION: The present study will evaluate the effect of an educational intervention based on a multifaceted pain control approach for elderly people who reside in nursing homes in order to reduce musculoskeletal pain in the elderly living in nursing homes. One of the features of this study is its focus on improving the health of elderly residents in nursing homes. Given the increase in the elderly population worldwide, the findings from the current trial might benefit elderly populations. TRIAL REGISTRATION: IRCT20220904055881N1 . Registered on 11 February 2023.


Sujet(s)
Maisons de retraite médicalisées , Douleur musculosquelettique , Maisons de repos , Humains , Douleur musculosquelettique/thérapie , Douleur musculosquelettique/psychologie , Douleur musculosquelettique/diagnostic , Sujet âgé , Essais contrôlés randomisés comme sujet , Vitamine D , Femelle , Mâle , Connaissances, attitudes et pratiques en santé , Adulte d'âge moyen , Techniques de physiothérapie , Résultat thérapeutique , Stress psychologique/thérapie , Stress psychologique/psychologie , Stress psychologique/prévention et contrôle , Sujet âgé de 80 ans ou plus , Éducation du patient comme sujet/méthodes
20.
J Bodyw Mov Ther ; 39: 323-329, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38876647

RÉSUMÉ

BACKGROUND: Cystic fibrosis (CF) is a severe genetic condition that affects multiple organ systems and imposes a substantial treatment burden. Regarding the lungs and airways, the progressive pathophysiological changes place a significant strain on the musculoskeletal components of the respiratory system for people with CF. This pilot study investigated the effectiveness of manual therapy interventions (MTIs) on thoracic mobility, respiratory muscle strength, lung function, and musculoskeletal pain. METHOD: A study with a pretest-posttest design was conducted with 15 eligible people with CF at the Sahlgrenska University Hospital CF Centre. After an initial set of diagnostic tests at baseline, the participants underwent eight weekly 30-min MTIs. The MTIs included passive joint mobilisation and soft tissue manipulation of primary and secondary anatomical areas of the musculoskeletal respiratory system. On the day of the final intervention, the baseline measurements were repeated. RESULTS: Trends of increased thoracic mobility were observed following the intervention, with a statistically significant increase in respiratory muscle strength. No change in lung function was observed. Musculoskeletal pain before and after the intervention showed a significant decrease in tender points, and all participants reported positive experiences with MTIs. CONCLUSION: MTIs may improve thoracic mobility, alleviate pain, and enhance respiratory muscle strength in people with CF. Further research is needed to confirm their potential role as a CF physiotherapy supplement. CLINICAL TRIAL ID: NCT04696198.


Sujet(s)
Mucoviscidose , Force musculaire , Manipulations de l'appareil locomoteur , Muscles respiratoires , Humains , Mucoviscidose/thérapie , Mucoviscidose/physiopathologie , Projets pilotes , Manipulations de l'appareil locomoteur/méthodes , Femelle , Mâle , Adulte , Force musculaire/physiologie , Muscles respiratoires/physiopathologie , Muscles respiratoires/physiologie , Jeune adulte , Douleur musculosquelettique/thérapie , Douleur musculosquelettique/rééducation et réadaptation , Tests de la fonction respiratoire , Adolescent
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE